Role of BAFF in Opsoclonus-Myoclonus syndrome, a bridge between cancer and autoimmunity
- PMID: 23610147
- DOI: 10.1189/jlb.0213106
Role of BAFF in Opsoclonus-Myoclonus syndrome, a bridge between cancer and autoimmunity
Abstract
OMS is a rare paraneoplastic disorder that affects adults and children. Pediatric OMS is often associated with NB, a common, solid tumor of childhood, derived from the sympathetic nervous system. The detection of autoantibodies and lymphocytic infiltration in NB patients led to advance an autoimmune hypothesis for the pathogenesis of OMS-related NB. BAFF is a potent modulator of B cell growth and survival upon interaction with its receptors BAFF-R and BCMA. The aim of this study was to investigate mechanism(s) involved in ectopic lymphoid neogenesis in OMS-associated NB. We investigated BAFF, BAFF-R, and BCMA expression in NB tumors associated or not with OMS. Furthermore, we evaluated BAFF expression and secretion in NB cell lines, treated or untreated with differentiating agents. Immunohistochemically, lymphocytes infiltrating NB tumors from patients, with or without OMS, expressed BAFF, BAFF-R, and BCMA, whereas neuroblasts expressed BAFF and BCMA but not BAFF-R. By flow cytometry, BAFF was found to be consistently expressed in NB cell lines. Similarly to the results obtained in tissue lesions, BCMA but not BAFF-R was detected on the surface of all NB cell lines under basal conditions. De novo synthesis of BAFF-R and up-regulation of BCMA were observed in NB cell lines upon treatment with IFN-γ or 13-cis retinoic acid. This study provides new insights in the mechanisms driving the neogenesis of lymphoid follicles and in the functional interactions between tumor and immune cells in OMS-associated NB.
Keywords: B lymphocytes; mechanisms of intratumor lymphoid neogenesis; neuroblastoma; paraneoplastic syndrome.
Similar articles
-
Immunological mechanisms in opsoclonus-myoclonus associated neuroblastoma.Eur J Paediatr Neurol. 2009 May;13(3):219-23. doi: 10.1016/j.ejpn.2008.04.012. Epub 2008 Jun 20. Eur J Paediatr Neurol. 2009. PMID: 18571942 Review.
-
Elevated B-cell activating factor BAFF, but not APRIL, correlates with CSF cerebellar autoantibodies in pediatric opsoclonus-myoclonus syndrome.J Neuroimmunol. 2009 May 29;210(1-2):87-91. doi: 10.1016/j.jneuroim.2009.03.006. Epub 2009 Mar 31. J Neuroimmunol. 2009. PMID: 19339060
-
Toll-like receptor 9 activation induces expression of membrane-bound B-cell activating factor (BAFF) on human B cells and leads to increased proliferation in response to both soluble and membrane-bound BAFF.Rheumatology (Oxford). 2013 Jul;52(7):1190-201. doi: 10.1093/rheumatology/ket006. Epub 2013 Feb 21. Rheumatology (Oxford). 2013. PMID: 23436580
-
Autoantibodies in childhood opsoclonus-myoclonus syndrome.J Neuroimmunol. 2008 Sep 15;201-202:221-6. doi: 10.1016/j.jneuroim.2008.05.033. Epub 2008 Aug 6. J Neuroimmunol. 2008. PMID: 18687475
-
TACI, an enigmatic BAFF/APRIL receptor, with new unappreciated biochemical and biological properties.Cytokine Growth Factor Rev. 2008 Jun-Aug;19(3-4):263-76. doi: 10.1016/j.cytogfr.2008.04.006. Epub 2008 Jun 2. Cytokine Growth Factor Rev. 2008. PMID: 18514565 Review.
Cited by
-
The "neuro" of neuroblastoma: Neuroblastoma as a neurodevelopmental disorder.Ann Neurol. 2016 Jul;80(1):13-23. doi: 10.1002/ana.24659. Epub 2016 Apr 30. Ann Neurol. 2016. PMID: 27043043 Free PMC article. Review.
-
Demographic, Clinical, and Immunologic Features of 389 Children with Opsoclonus-Myoclonus Syndrome: A Cross-sectional Study.Front Neurol. 2017 Sep 11;8:468. doi: 10.3389/fneur.2017.00468. eCollection 2017. Front Neurol. 2017. PMID: 28959231 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials